XETRA - Delayed Quote EUR

aap Implantate AG (AAQ1.DE)

Compare
1.6700
0.0000
(0.00%)
As of January 14 at 5:36:28 PM GMT+1. Market Open.
Loading Chart for AAQ1.DE
DELL
  • Previous Close 1.6700
  • Open 1.6500
  • Bid 1.6000 x --
  • Ask 1.7300 x --
  • Day's Range 1.6500 - 1.7300
  • 52 Week Range 0.7000 - 2.9800
  • Volume 578
  • Avg. Volume 3,274
  • Market Cap (intraday) 20.17M
  • Beta (5Y Monthly) -0.36
  • PE Ratio (TTM) --
  • EPS (TTM) -0.4800
  • Earnings Date Feb 13, 2025 - Feb 17, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. It offers LOQTEQ, an anatomical plating system for fracture treatment of ankle joint, knee, elbow, wrist, and shoulder; and straight plates and cannulated screws. The company sells its products directly to hospitals, purchasing groups, and hospital groups in Germany through a network of distributors. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.

www.aap.de

87

Full Time Employees

December 31

Fiscal Year Ends

Recent News: AAQ1.DE

View More

Performance Overview: AAQ1.DE

Trailing total returns as of 1/15/2025, which may include dividends or other distributions. Benchmark is

.

YTD Return

AAQ1.DE
25.56%
DAX P
2.00%

1-Year Return

AAQ1.DE
104.91%
DAX P
21.56%

3-Year Return

AAQ1.DE
49.70%
DAX P
27.85%

5-Year Return

AAQ1.DE
58.34%
DAX P
50.90%

Compare To: AAQ1.DE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: AAQ1.DE

View More

Valuation Measures

As of 1/14/2025
  • Market Cap

    20.17M

  • Enterprise Value

    23.82M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.21

  • Price/Book (mrq)

    1.63

  • Enterprise Value/Revenue

    2.08

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -19.32%

  • Return on Assets (ttm)

    -11.28%

  • Return on Equity (ttm)

    -17.22%

  • Revenue (ttm)

    11.96M

  • Net Income Avi to Common (ttm)

    -2.31M

  • Diluted EPS (ttm)

    -0.4800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    780k

  • Total Debt/Equity (mrq)

    27.02%

  • Levered Free Cash Flow (ttm)

    -1.8M

Research Analysis: AAQ1.DE

View More

People Also Watch